









Mercado
/
Acciones
/
nasdaq-lnth
/

Lantheus Holdings Inc

LNTH

64.890USD

+0.030+0.05%

Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min

4.30BCap. mercado

26.34P/E TTM



Lantheus Holdings Inc

64.890

+0.030+0.05%

Descripción general Finanzas Análisis Compañía

Descripción general

Finanzas

Análisis

Compañía

Más Datos de Lantheus Holdings Inc Compañía

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, Neuraceq, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, among others. The Neuraceq (florbetaben F18 injection) is an F-18 PET imaging agent for Alzheimer’s disease.

Información de Lantheus Holdings Inc



Símbolo de cotizaciónLNTH

Nombre de la empresaLantheus Holdings Inc

Fecha de salida a bolsaJun 25, 2015

Director ejecutivoMarkison (Brian A)

Número de empleados808

Tipo de seguridadOrdinary Share

Fin del año fiscalJun 25

Dirección331 Treble Cove Road

CiudadNORTH BILLERICA

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited States of America

Código postal01862

Teléfono19786718001

Sitio Webhttps://www.lantheus.com/

Símbolo de cotizaciónLNTH

Fecha de salida a bolsaJun 25, 2015

Director ejecutivoMarkison (Brian A)

Ejecutivos de Lantheus Holdings Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Ms. Mary Anne Heino

Executive Chairman of the Board, Interim Executive Officer

599.01K

+14285.00%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+60654.00%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-17901.00%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+2537.00%

Dr. Gerard Ber, Ph.D.

Independent Director

23.36K

+2141.00%

Ms. Minnie Baylor-Henry, J.D.

Independent Director

9.90K

+2537.00%

Dr. Phuong Khanh (P. K.) Morrow, M.D.

Independent Director

3.10K

+2537.00%

Mr. Samuel R. (Sam) Leno

Independent Director

Ms. Julie H. Mchugh

Lead Independent Director

Mr. Gary John Pruden

Independent Director

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Ms. Mary Anne Heino

Executive Chairman of the Board, Interim Executive Officer

599.01K

+14285.00%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+60654.00%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-17901.00%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+2537.00%

Dr. Gerard Ber, Ph.D.

Independent Director

23.36K

+2141.00%

Ms. Minnie Baylor-Henry, J.D.

Independent Director

9.90K

+2537.00%

Desglose de ingresos

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

PYLARIFY

240.62M

0.00%

DEFINITY

81.78M

0.00%

TechneLite

21.13M

0.00%

Neuraceq

20.44M

0.00%

Strategic partnerships and other

13.71M

0.00%

Other precision diagnostics

6.34M

0.00%

La empresa aún no ha revelado los datos relevantes.

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

PYLARIFY

240.62M

0.00%

DEFINITY

81.78M

0.00%

TechneLite

21.13M

0.00%

Neuraceq

20.44M

0.00%

Strategic partnerships and other

13.71M

0.00%

Other precision diagnostics

6.34M

0.00%

Estadísticas de accionistas

Actualizado: dom., 11 de ene

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

11.00%

Janus Henderson Investors

10.08%

The Vanguard Group, Inc.

10.06%

Morgan Stanley & Co. LLC

5.55%

Farallon Capital Management, L.L.C.

5.24%

Otro

58.08%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

11.00%

Janus Henderson Investors

10.08%

The Vanguard Group, Inc.

10.06%

Morgan Stanley & Co. LLC

5.55%

Farallon Capital Management, L.L.C.

5.24%

Otro

58.08%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

51.50%

Investment Advisor/Hedge Fund

36.38%

Research Firm

8.68%

Hedge Fund

8.11%

Individual Investor

2.40%

Pension Fund

1.78%

Sovereign Wealth Fund

0.77%

Bank and Trust

0.72%

Family Office

0.13%

Participación institucional



Actualizado: jue., 1 de ene

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q4

1029

71.74M

108.19%

-15.56M

2025Q3

1018

78.96M

119.07%

-8.67M

2025Q2

1039

82.20M

120.88%

-4.84M

2025Q1

1066

83.20M

120.27%

-2.89M

2024Q4

1033

78.65M

114.86%

-4.64M

2024Q3

1003

73.69M

106.06%

-7.92M

2024Q2

959

71.82M

103.63%

-10.29M

2024Q1

912

71.21M

103.87%

-11.25M

2023Q4

868

73.50M

107.32%

-9.24M

2023Q3

828

74.80M

109.31%

-3.81M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

7.29M

11%

-208.45K

-2.78%

Sep 30, 2025

Janus Henderson Investors

6.68M

10.08%

-254.25K

-3.66%

Sep 30, 2025

The Vanguard Group, Inc.

6.92M

10.44%

+100.16K

+1.47%

Sep 30, 2025

Morgan Stanley & Co. LLC

3.68M

5.55%

+3.18M

+635.59%

Sep 30, 2025

Farallon Capital Management, L.L.C.

3.48M

5.24%

+161.00K

+4.85%

Sep 30, 2025

Fidelity Management & Research Company LLC

3.10M

4.68%

-1.03M

-24.93%

Sep 30, 2025

State Street Investment Management (US)

2.50M

3.77%

-61.59K

-2.41%

Sep 30, 2025

Geode Capital Management, L.L.C.

1.75M

2.65%

-22.43K

-1.26%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

1.37M

2.07%

-12.04K

-0.87%

Sep 30, 2025

Reinhart Partners, LLC

1.35M

2.03%

-55.90K

-3.98%

Sep 30, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

State Street SPDR S&P Health Care Equipment ETF

1.96%

Invesco S&P MidCap 400 GARP ETF

1.69%

First Trust Small Cap US Equity Select ETF

1.07%

VictoryShares Small Cap Free Cash Flow ETF

0.93%

Invesco S&P MidCap 400 Pure Growth ETF

0.74%

Distillate Small/Mid Cash Flow ETF

0.66%

Pacer US Small Cap Cash Cows ETF

0.56%

Gotham 1000 Value ETF

0.5%

Invesco S&P MidCap Quality ETF

0.47%

Pacer US Cash Cows Growth ETF

0.47%

State Street SPDR S&P Health Care Equipment ETF

Proporción1.96%

Invesco S&P MidCap 400 GARP ETF

Proporción1.69%

First Trust Small Cap US Equity Select ETF

Proporción1.07%

VictoryShares Small Cap Free Cash Flow ETF

Proporción0.93%

Invesco S&P MidCap 400 Pure Growth ETF

Proporción0.74%

Distillate Small/Mid Cash Flow ETF

Proporción0.66%

Pacer US Small Cap Cash Cows ETF

Proporción0.56%

Gotham 1000 Value ETF

Proporción0.5%

Invesco S&P MidCap Quality ETF

Proporción0.47%

Pacer US Cash Cows Growth ETF

Proporción0.47%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

KeyAI

